Effective as of January 1, 2014, the board of directors of ResMed Inc. approved the appointment of Dr. Peter Farrell, current executive chairman of the board of directors, as non-executive chairman of the board. As part of the transition, Dr. Farrell will no longer be an executive officer of the company, although he will remain a non-officer employee.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
212.3 USD | +0.91% | +0.65% | +23.40% |
06-11 | Resmed Insider Sold Shares Worth $3,107,739, According to a Recent SEC Filing | MT |
05-23 | ResMed Says Research Shows Effectiveness of Positive Airway Pressure Therapy For Sleep Apnea | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.40% | 31.18B | |
+7.23% | 217B | |
+11.31% | 191B | |
+28.94% | 154B | |
+32.00% | 112B | |
-0.46% | 62.75B | |
+16.09% | 53.34B | |
+0.94% | 48.88B | |
-2.97% | 39.36B | |
+1.23% | 35.73B |
- Stock Market
- Equities
- RMD Stock
- News ResMed, Inc.
- ResMed Inc. Appoints Dr. Peter Farrell as Non-Executive Chairman of the Board